ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

8,415Medicare Part D Prescriptions Filled, Including Refills

Rank: 12 out of 143

$598K Total Retail Price of All Prescriptions

Rank: 18 out of 143

464 Patients Receiving at Least One Drug in Part D
84%Patients 65 Years and Older
11% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Delaware
Lower avg

Schedule Two
Controlled Substances

12% of this provider’s 464 patients filled at least one prescription for a schedule two drug, compared to an average of 7%.

Schedule Three
Controlled Substances

8% of this provider’s 464 patients filled at least one prescription for a schedule three drug, compared to an average of 5%.

Risky Drugs to Seniors

1% of this provider’s 7,845 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

26% of this provider’s prescriptions were for brand-name drugs, compared to an average of 28%.

Prescription Price

$71 was the average price of a prescription from this provider, compared to $79 among peers.

Prescriptions per Patient

18 is the average number of prescriptions (including refills) per patient, compared to an average of 16.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Delaware
OMEPRAZOLE 262 249 1 5
WARFARIN SODIUM 249 247 2 15
LEVOTHYROXINE SODIUM 238 233 3 3
LISINOPRIL 235 222 4 1
AMLODIPINE BESYLATE 232 220 5 4
FUROSEMIDE 202 200 6 6
TRAMADOL HCL 186 174 7 16
PRAVASTATIN SODIUM 171 166 8 9
SIMVASTATIN 135 134 9 2
ATENOLOL 133 128 10 11
MIRTAZAPINE 127 123 11 30
ZOLPIDEM TARTRATE 125 113 12 13
ATORVASTATIN CALCIUM 125 115 12 7
HYDROCODONE-ACETAMINOPHEN 112 79 S3 14 20
METOPROLOL TARTRATE 107 105 15 12
NAMENDA 105 105 16 49
LORAZEPAM 98 98 17 175
DONEPEZIL HCL 92 92 18 36
PREDNISONE 91 89 19 35
TRIAMTERENE-HCTZ 90 86 20 89
ESCITALOPRAM OXALATE 88 87 21 46
SERTRALINE HCL 80 77 22 23
SYNTHROID 79 79 23 24
ALENDRONATE SODIUM 78 70 24 40
CARBIDOPA-LEVODOPA 77 77 25 93
INDAPAMIDE 76 75 26 134
CITALOPRAM HBR 75 73 27 25
QUETIAPINE FUMARATE 74 68 28 53
RISPERIDONE 73 73 29 61
POTASSIUM CHLORIDE 72 72 30 34
METOPROLOL SUCCINATE 72 66 30 14
GABAPENTIN 70 66 32 18
LEVOFLOXACIN 70 63 32 68
CELEBREX 61 54 34 70
DOXAZOSIN MESYLATE 60 58 35 91
FENTANYL 59 59 S2 36 83
METFORMIN HCL 57 57 37 8
TRAZODONE HCL 57 55 37 59
NEXIUM 56 55 39 32
TAMSULOSIN HCL 55 51 40 28
IBUPROFEN 54 28 41 117
NYSTOP 52 52 42 218
DIGOXIN 52 52 42 71
CYMBALTA 51 51 44 47
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Feb. 18, 2014.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.